Skip to main content
Premium Trial:

Request an Annual Quote

Genetix Launches Robotic System for Genomic Libraries, Plans Launch of Low-cost Microarrayer

NEW YORK, July 10 – Genetix of Hampshire, UK, announced Tuesday the launch of an automated robotic system for managing and developing genomic and cDNA libraries.

Using robotics, the new system, Qselect, is capable of screening cDNA and genomic libraries and then replicating designated samples.

“Until now, people would do this manually, with handheld pin devices,” said Susan Richards, worldwide sales and marketing manager for Genetix. “This allows you to make rapid replicas.”

The system has the capacity for 420 96- or 384-wellplates.

Richards said that initial interest in the system was strong, although no sales have been made yet.

In addition to Qselect, Richards said Genetix was gearing up for the launch of a new microarrayer, which will have high slide and plate capacity but will be compact enough to fit in a small laboratory.

The new microarrayer, which will use a spotting device to make oligo and/or cDNA microarrays, is expected to sell for $25,000.

Although Richards declined to offer any details about the new machine, she said that “it will be as fast as anything on the market currently.”

The company is also in the process of developing a protein excision system.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.